The 4th edition of The European Code Against Cancer produced by The International Agency for Cancer Research (IARC) presents information on 12 ways to adopt healthier lifestyles and boost cancer prevention across Europe. The work is focussed on individual action that all European citizens can make to significantly reduce their risk of developing cancer.

The Code notes the importance of avoiding tobacco, alcohol, and excessive sun exposure and the importance of maintaining a healthy body weight and being physically active. It also recommends participation in screening programmes for bowel, breast, and cervical cancer screening.

This edition of the Code includes other important recommendations to reduce cancer risk beyond  lifestyle such as vaccination programmes against human papillomavirus, breastfeeding, and limiting the use of hormone replacement therapy. It also recommends finding out about potential exposure to radiation from radon at home and supporting action to reduce high radon levels.

For more information (including Frequently asked Q and A) see http://cancer-code-europe.iarc.fr/index.php/en/.

  • New PhD Opportunity: Doctoral Training Fellowship in Cancer Prevention

    DEADLINE EXTENDED TO 31ST MAY 2021 The Scottish Cancer Foundation (SCF) focuses on Cancer Prevention, and wishes to promote research, collaborative working across Scotland and public engagement in this area.  Accordingly, the Foundation wishes to invest in the future of Cancer Prevention by providing motivated early-career individuals with research training

  • The Scottish Cancer Foundation Prize & Evans Forrest Medal

    The Scottish Cancer Foundation invites nominations for the 2021 Prize which will be for an individual or organisation that has made an outstanding contribution to the maintenance and/or recovery of cancer services during the COVID-19 pandemic. Applicants may be nominated or self-nominated. The applicant(s) must be living and working in

  • SCPN e-digest – Issue 3 – November 2020

    All articles from the e-digest can be viewed here

  • Scottish Cancer Foundation PhD Opportunity

    We are excited to advertise shortly a new Scottish Cancer Foundation PhD Studentship looking at improving cancer preventive behaviours in cancer patients and their families. Cancer prevention is vital given ever increasing cancer cases and spiralling costs of cancer treatment. The challenge is that supporting people to live a cancer preventive lifestyle (not smoking, being

  • SCPN e-digest Issue 2

    All articles from this issue can be accessed here

  • Skydive Fundraising Success for SCF

    When Elma Nicoll jumped out of a plane thousands of feet over Perthshire, the Scottish Cancer Foundation earned almost £27 for every 100 feet she dropped.   Elma was fulfilling a lifelong ambition to take part in a skydive and, in the process, honoured the memory of her father and

  • The Latest SCF Newsletter is Out Now!

    This issue focuses on this year’s winner of the Scottish Cancer Prevention Prize and Evans Forrest Medal, Dr Christine Campbell. There’s also important information about the aims and activities of Scottish Cancer Foundation, and the success of one of our previous medal winners, Sheila Duffy, Chief Executive of ASH Scotland. 

  • Major honour for Scots researcher

    A Scots researcher whose work on cancer screening has helped to save lives around the world is this year’s winner of the Scottish Cancer Foundation prize which recognises excellence in cancer care and prevention.   Dr Christine Campbell, of the University of Edinburgh’s Usher Institute, has led a series of

  • SCF Lecture: Prostate Cancer- a disease of our time

    On Monday 17th June at 6pm, Scottish Cancer Foundation alongside the Royal Society of Edinburgh hosted a lecture on Prostate cancer delivered by Freddie C. Hamdy FRCSEd, FRCS, FMedSci, Nuffield Professor of Surgery & Urology, University of Oxford. Freddie Hamdy is the Nuffield Professor of Surgery at the University of Oxford, UK,

  • Scottish Cancer Foundation Lecture

    Prostate Cancer: a disease of our time Prostate cancer continues to pose considerable controversies, and to attract interest and attention from the public, the media, scientists and urologists alike. From molecular biology and gigantic leaps in technology, to high-quality randomised controlled trials of screening and treatment, never before has the